Neil E. Reiner
Directeur Technique/Scientifique/R&D chez Indel Therapeutics, Inc.
Profil
Neil E.
Reiner is currently the Director & Chief Scientific Officer at Indel Therapeutics, Inc., the Director-Immunity & Infectious Research Center at Vancouver Coastal Health Research Institute, and a Professor at the University of British Columbia.
He previously served as the Head-Infectious Diseases Division at Vancouver General Hospital.
Postes actifs de Neil E. Reiner
| Sociétés | Poste | Début |
|---|---|---|
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Directeur Technique/Scientifique/R&D | 29/04/2011 |
| University of British Columbia | Corporate Officer/Principal | 29/04/2011 |
Vancouver Coastal Health Research Institute
 Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | - |
Anciens postes connus de Neil E. Reiner
| Sociétés | Poste | Fin |
|---|---|---|
| Vancouver General Hospital | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Vancouver General Hospital | |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Indel Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of antibiotics to address the health crisis caused by antibiotics resistance. The firm’s programs are based on Indel's paradigm-changing antimicrobial drug discovery platform that has opened drug targets for the treatment of bacterial and parasitic infections, and potentially, fungal and viral infections. The company was founded by Malcolm C. Kendall in 2008 and is headquartered in Vancouver, Canada.^ ^ | Health Technology |
Vancouver Coastal Health Research Institute
Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada. | Commercial Services |
